Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor 20mg/Glucophage SR 750mg
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate safety and pharmacokinetic properties of the two
treatments, the administration of CJ-30056 and the co-administration of atorvastatin 20mg and
metformin SR 750mg, in healthy volunteers.